Shirley Liao

Major depressive disorder prevalence and risk factors among Syrian asylum seekers in Greece

Danielle N. Poole, Bethany Hedt‐Gauthier, Shirley Liao et al. · BMC Public Health · 2018 · 95 citations · Full text

Uncertainty in the design stage of two‐stage Bayesian propensity score analysis

Shirley Liao, Corwin Zigler · Statistics in Medicine · 2020 · 23 citations · Full text

No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS

Lana Zhovtis Ryerson, Robert T. Naismith, Lauren Krupp et al. · Multiple Sclerosis and Related Disorders · 2022 · 20 citations · Full text

No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score–matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP)

Helmut Butzkueven, Ludwig Kappos, Tim Spelman et al. · Therapeutic Advances in Neurological Disorders · 2021 · 18 citations · Full text

Sequential screening for depression in humanitarian emergencies: a validation study of the Patient Health Questionnaire among Syrian refugees

Danielle N. Poole, Shirley Liao, Elysia Larson et al. · Annals of General Psychiatry · 2020 · 16 citations · Full text